ImmunoGen Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Nov 23 | SellUS$1,513,970 | Renee Lentini | Individual | 99,017 | US$15.29 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,254 | 0.00196% |
Individual Insiders | 1,004,547 | 0.375% |
General Public | 14,766,766 | 5.52% |
Hedge Funds | 17,503,417 | 6.54% |
Institutions | 234,382,450 | 87.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
24,482,155 | US$764.6m | 17.1% | 0.01% | |||
21,823,243 | US$681.5m | 7.64% | 0.01% | |||
17,684,816 | US$552.3m | 14.1% | 0.24% | |||
17,503,417 | US$546.6m | -1.28% | 16.56% | |||
13,322,288 | US$416.1m | 472% | 5.41% | |||
13,258,997 | US$414.1m | 36% | 0.06% | |||
8,075,671 | US$252.2m | -15.5% | 0.01% | |||
6,995,239 | US$218.5m | 11.4% | 0.35% | |||
5,929,592 | US$185.2m | -1.66% | 13.37% | |||
5,788,099 | US$180.8m | 3.13% | 0.01% | |||
5,539,334 | US$173.0m | 0% | 0.02% | |||
4,899,975 | US$153.0m | 3.1% | 0.01% | |||
4,331,504 | US$135.3m | 46.1% | 0.02% | |||
3,906,370 | US$122.0m | 68.2% | 0.01% | |||
3,724,583 | US$116.3m | -0.04% | 0.09% | |||
3,708,139 | US$115.8m | 414% | 0.08% | |||
3,044,485 | US$95.1m | 2.04% | 2.52% | |||
2,961,000 | US$92.5m | 0% | 4.0% | |||
2,933,190 | US$91.6m | -10.5% | 2.13% | |||
2,886,241 | US$90.1m | 0% | 0.02% | |||
2,518,527 | US$78.7m | -33.5% | 1.63% | |||
2,512,251 | US$78.5m | 23.7% | 0.34% | |||
2,433,161 | US$76.0m | -4.49% | 0.81% | |||
2,370,864 | US$74.0m | -1.05% | 0.01% | |||
2,045,202 | US$63.9m | 147% | 3.04% |